{"transactions":[{"id":2057502,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-10T21:14:46.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":98,"price":62.305,"value":6105.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2022 through December 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022."}],"balance_after":28770,"source":{"system":"sec-edgar","filing":"0001645113-23-000012","document":"wf-form4_167338526960077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000012/wf-form4_167338526960077.xml","form_type":"4"}},{"id":2194474,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-04T20:32:39.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":5396,"price":74,"value":399304.0,"ownership":{"direct":true},"balance_after":28672,"source":{"system":"sec-edgar","filing":"0001645113-22-000073","document":"wf-form4_165964508670843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000073/wf-form4_165964508670843.xml","form_type":"4"}},{"id":2194473,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-04T20:32:39.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":563,"price":71.09,"value":40023.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":34068,"source":{"system":"sec-edgar","filing":"0001645113-22-000073","document":"wf-form4_165964508670843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000073/wf-form4_165964508670843.xml","form_type":"4"}},{"id":2195788,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:44:23.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":437,"price":69.659,"value":30440.983,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":34631,"source":{"system":"sec-edgar","filing":"0001645113-22-000070","document":"wf-form4_165955944560794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000070/wf-form4_165955944560794.xml","form_type":"4"}},{"id":2210745,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:47:30.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":222,"price":59.075,"value":13114.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2022 through June 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022."}],"balance_after":35068,"source":{"system":"sec-edgar","filing":"0001645113-22-000061","document":"wf-form4_165723043635515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000061/wf-form4_165723043635515.xml","form_type":"4"}},{"id":2273512,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-12T20:30:12.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":2135,"price":61.25,"value":130768.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":34846,"source":{"system":"sec-edgar","filing":"0001645113-22-000046","document":"wf-form4_165238737966787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000046/wf-form4_165238737966787.xml","form_type":"4"}},{"id":2273511,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-12T20:30:12.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":2070,"price":65.158,"value":134877.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amended total to correct prior mathematical error."}],"balance_after":36981,"source":{"system":"sec-edgar","filing":"0001645113-22-000046","document":"wf-form4_165238737966787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000046/wf-form4_165238737966787.xml","form_type":"4"}},{"id":2347772,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:18:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":5452,"price":80.59,"value":439376.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Options to buy 5,452 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":5452,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":5452},"source":{"system":"sec-edgar","filing":"0001645113-22-000017","document":"wf-form4_164669511463233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000017/wf-form4_164669511463233.xml","form_type":"4"}},{"id":2347771,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:18:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":30422,"price":80.59,"value":2451708.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":30422,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":30422},"source":{"system":"sec-edgar","filing":"0001645113-22-000017","document":"wf-form4_164669511463233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000017/wf-form4_164669511463233.xml","form_type":"4"}},{"id":2347770,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:18:57.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":1510,"price":70.407,"value":106314.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":43257,"source":{"system":"sec-edgar","filing":"0001645113-22-000017","document":"wf-form4_164669511463233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000017/wf-form4_164669511463233.xml","form_type":"4"}},{"id":2347769,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:18:57.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":803,"price":74.498,"value":59821.894,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":44767,"source":{"system":"sec-edgar","filing":"0001645113-22-000017","document":"wf-form4_164669511463233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000017/wf-form4_164669511463233.xml","form_type":"4"}},{"id":2347768,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:18:57.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":17371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":45570,"source":{"system":"sec-edgar","filing":"0001645113-22-000017","document":"wf-form4_164669511463233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000017/wf-form4_164669511463233.xml","form_type":"4"}},{"id":2436840,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-12T22:38:37.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":55,"price":63.818,"value":3509.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2021 through December 31, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2021."}],"balance_after":28199,"source":{"system":"sec-edgar","filing":"0001645113-22-000006","document":"wf-form4_164202710572487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000006/wf-form4_164202710572487.xml","form_type":"4"}},{"id":2614846,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-04T20:59:21.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":464,"price":150.11,"value":69651.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":28144,"source":{"system":"sec-edgar","filing":"0001645113-21-000095","document":"wf-form4_162811071615273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000095/wf-form4_162811071615273.xml","form_type":"4"}},{"id":2617762,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-03T21:29:28.000Z","date":"2021-07-30","kind":"exercise","acquired":false,"shares":651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":3253,"derivative":{"exercise_price":83.3,"expiration_date":"2029-07-30","underlying":"Ordinary Shares","underlying_shares":651},"source":{"system":"sec-edgar","filing":"0001645113-21-000094","document":"wf-form4_162802611472815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000094/wf-form4_162802611472815.xml","form_type":"4"}},{"id":2617761,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-03T21:29:28.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":536,"price":149.378,"value":80066.608,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":28608,"source":{"system":"sec-edgar","filing":"0001645113-21-000094","document":"wf-form4_162802611472815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000094/wf-form4_162802611472815.xml","form_type":"4"}},{"id":2617760,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-03T21:29:28.000Z","date":"2021-07-30","kind":"sale","acquired":false,"shares":651,"price":158.96,"value":103482.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29144,"source":{"system":"sec-edgar","filing":"0001645113-21-000094","document":"wf-form4_162802611472815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000094/wf-form4_162802611472815.xml","form_type":"4"}},{"id":2617759,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-03T21:29:28.000Z","date":"2021-07-30","kind":"exercise","acquired":true,"shares":651,"price":83.3,"value":54228.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29795,"source":{"system":"sec-edgar","filing":"0001645113-21-000094","document":"wf-form4_162802611472815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000094/wf-form4_162802611472815.xml","form_type":"4"}},{"id":2638085,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-08T21:32:45.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":90,"price":137.122,"value":12340.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2021 through June 30, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021."}],"balance_after":29144,"source":{"system":"sec-edgar","filing":"0001645113-21-000085","document":"wf-form4_162577994550029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000085/wf-form4_162577994550029.xml","form_type":"4"}},{"id":2691286,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-05-28T20:36:12.000Z","date":"2021-05-27","kind":"exercise","acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":7332,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-07","underlying":"Ordinary Shares","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001645113-21-000069","document":"wf-form4_162223413522679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000069/wf-form4_162223413522679.xml","form_type":"4"}},{"id":2691285,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-28T20:36:12.000Z","date":"2021-05-27","kind":"sale","acquired":false,"shares":1833,"price":200,"value":366600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29054,"source":{"system":"sec-edgar","filing":"0001645113-21-000069","document":"wf-form4_162223413522679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000069/wf-form4_162223413522679.xml","form_type":"4"}},{"id":2691284,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-28T20:36:12.000Z","date":"2021-05-27","kind":"exercise","acquired":true,"shares":1833,"price":47.56,"value":87177.48,"ownership":{"direct":true},"balance_after":30887,"source":{"system":"sec-edgar","filing":"0001645113-21-000069","document":"wf-form4_162223413522679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000069/wf-form4_162223413522679.xml","form_type":"4"}},{"id":2712307,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-14T20:07:43.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":1943,"price":180.48,"value":350672.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29054,"source":{"system":"sec-edgar","filing":"0001645113-21-000068","document":"wf-form4_162102283236308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000068/wf-form4_162102283236308.xml","form_type":"4"}},{"id":2716394,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-05-12T20:15:39.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":9165,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-07","underlying":"Ordinary Shares","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001645113-21-000067","document":"wf-form4_162085051621853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000067/wf-form4_162085051621853.xml","form_type":"4"}},{"id":2716393,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:15:39.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":2262,"price":180.118,"value":407426.916,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":30997,"source":{"system":"sec-edgar","filing":"0001645113-21-000067","document":"wf-form4_162085051621853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000067/wf-form4_162085051621853.xml","form_type":"4"}},{"id":2716392,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:15:39.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":1833,"price":189.65,"value":347628.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001645113-21-000067","document":"wf-form4_162085051621853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000067/wf-form4_162085051621853.xml","form_type":"4"}},{"id":2716391,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:15:39.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":1833,"price":47.56,"value":87177.48,"ownership":{"direct":true},"balance_after":35092,"source":{"system":"sec-edgar","filing":"0001645113-21-000067","document":"wf-form4_162085051621853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000067/wf-form4_162085051621853.xml","form_type":"4"}},{"id":2748611,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":3474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":19404,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":3474},"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748610,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":3904,"derivative":{"exercise_price":83.3,"expiration_date":"2029-07-30","underlying":"Ordinary Shares","underlying_shares":651},"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748609,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":10998,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-07","underlying":"Ordinary Shares","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748608,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":3474,"price":200,"value":694800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748607,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":3474,"price":69.37,"value":240991.38,"ownership":{"direct":true},"balance_after":36733,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748606,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":651,"price":200,"value":130200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748605,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":651,"price":83.3,"value":54228.3,"ownership":{"direct":true},"balance_after":33910,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748604,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1833,"price":200,"value":366600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2748603,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-15T21:59:18.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":1833,"price":47.56,"value":87177.48,"ownership":{"direct":true},"balance_after":35092,"source":{"system":"sec-edgar","filing":"0001645113-21-000053","document":"wf-form4_161852392575490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000053/wf-form4_161852392575490.xml","form_type":"4"}},{"id":2799953,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-09T21:16:07.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":2918,"price":131.53,"value":383804.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001645113-21-000041","document":"wf-form4_161532454290586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000041/wf-form4_161532454290586.xml","form_type":"4"}},{"id":2806190,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-05T22:44:42.000Z","date":"2021-03-03","kind":"exercise","acquired":false,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":22878,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001645113-21-000036","document":"wf-form4_161498426934871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000036/wf-form4_161498426934871.xml","form_type":"4"}},{"id":2806189,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-05T22:44:42.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":1888,"price":137.554,"value":259701.952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units vested on March 3, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":36177,"source":{"system":"sec-edgar","filing":"0001645113-21-000036","document":"wf-form4_161498426934871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000036/wf-form4_161498426934871.xml","form_type":"4"}},{"id":2806188,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-05T22:44:42.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":3475,"price":150.78,"value":523960.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":38065,"source":{"system":"sec-edgar","filing":"0001645113-21-000036","document":"wf-form4_161498426934871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000036/wf-form4_161498426934871.xml","form_type":"4"}},{"id":2806187,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-05T22:44:42.000Z","date":"2021-03-03","kind":"exercise","acquired":true,"shares":3475,"price":69.37,"value":241060.75,"ownership":{"direct":true},"balance_after":41540,"source":{"system":"sec-edgar","filing":"0001645113-21-000036","document":"wf-form4_161498426934871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000036/wf-form4_161498426934871.xml","form_type":"4"}},{"id":2808854,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-04T22:53:25.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":16003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 16,003 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":16003,"derivative":{"exercise_price":153.09,"expiration_date":"2031-03-01","underlying":"Ordinary Shares","underlying_shares":16003},"source":{"system":"sec-edgar","filing":"0001645113-21-000031","document":"wf-form4_161489839039798.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000031/wf-form4_161489839039798.xml","form_type":"4"}},{"id":2808853,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:53:25.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":8709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":38065,"source":{"system":"sec-edgar","filing":"0001645113-21-000031","document":"wf-form4_161489839039798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000031/wf-form4_161489839039798.xml","form_type":"4"}},{"id":2934688,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":4555,"derivative":{"exercise_price":83.3,"expiration_date":"2029-07-30","underlying":"Ordinary Shares","underlying_shares":651},"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":2934687,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":12831,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-07","underlying":"Ordinary Shares","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":2934686,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":651,"price":156.71,"value":102018.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29356,"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":2934685,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":651,"price":83.3,"value":54228.3,"ownership":{"direct":true},"balance_after":30007,"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":2934684,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":1833,"price":156.71,"value":287249.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29356,"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":2934683,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-22T23:39:27.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":1833,"price":47.56,"value":87177.48,"ownership":{"direct":true},"balance_after":31189,"source":{"system":"sec-edgar","filing":"0001628280-20-017712","document":"wf-form4_160868035486570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000162828020017712/wf-form4_160868035486570.xml","form_type":"4"}},{"id":3067493,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-05T20:11:21.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":660,"price":76.06,"value":50199.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":29356,"source":{"system":"sec-edgar","filing":"0001645113-20-000115","document":"wf-form4_159665826501157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000115/wf-form4_159665826501157.xml","form_type":"4"}},{"id":3071384,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:53:42.000Z","date":"2020-07-31","kind":"sale","acquired":false,"shares":341,"price":76.388,"value":26048.308,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":30016,"source":{"system":"sec-edgar","filing":"0001645113-20-000114","document":"wf-form4_159649157316820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000114/wf-form4_159649157316820.xml","form_type":"4"}},{"id":3071383,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:53:42.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":325,"price":50.405,"value":16381.625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2020 through June 30, 2020.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amended total to correct prior mathematical error."}],"balance_after":30357,"source":{"system":"sec-edgar","filing":"0001645113-20-000114","document":"wf-form4_159649157316820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000114/wf-form4_159649157316820.xml","form_type":"4"}},{"id":3148987,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-14T20:14:57.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":2595,"price":64.78,"value":168104.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim."}],"balance_after":12616,"source":{"system":"sec-edgar","filing":"0001645113-20-000083","document":"wf-form4_158948727942417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000083/wf-form4_158948727942417.xml","form_type":"4"}},{"id":3152762,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2020-05-12T20:22:54.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":4206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":8410,"derivative":{"exercise_price":0,"exercise_date":"2020-05-08","underlying":"Ordinary Shares","underlying_shares":4206},"source":{"system":"sec-edgar","filing":"0001645113-20-000079","document":"wf-form4_158931495360958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000079/wf-form4_158931495360958.xml","form_type":"4"}},{"id":3152761,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-12T20:22:54.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":1611,"price":63.728,"value":102665.808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":15211,"source":{"system":"sec-edgar","filing":"0001645113-20-000079","document":"wf-form4_158931495360958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000079/wf-form4_158931495360958.xml","form_type":"4"}},{"id":3152760,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-12T20:22:54.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":4206,"price":63.84,"value":268511.04,"ownership":{"direct":true},"balance_after":16822,"source":{"system":"sec-edgar","filing":"0001645113-20-000079","document":"wf-form4_158931495360958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000079/wf-form4_158931495360958.xml","form_type":"4"}},{"id":3224567,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-03-05T23:46:27.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":27794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 27,794 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":27794,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":27794},"source":{"system":"sec-edgar","filing":"0001632237-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000163223720000001/primary_doc.xml","form_type":"4"}},{"id":3224566,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-05T23:46:27.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":14415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":30032,"source":{"system":"sec-edgar","filing":"0001632237-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000163223720000001/primary_doc.xml","form_type":"4"}},{"id":3451058,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-08-01T20:10:55.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":5206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 5,206 ordinary shares will fully vest and become exercisable in equal installments on each of July 30, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":5206,"derivative":{"exercise_price":83.3,"expiration_date":"2029-07-30","underlying":"Ordinary Shares","underlying_shares":5206},"source":{"system":"sec-edgar","filing":"0001209191-19-044006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044006/doc4.xml","form_type":"4"}},{"id":3451057,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-01T20:10:55.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":3001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of these restricted stock units are scheduled to vest on each of July 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":15617,"source":{"system":"sec-edgar","filing":"0001209191-19-044006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044006/doc4.xml","form_type":"4"}},{"id":3622908,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:35:43.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 9,500 RSUs, of which 2,375 vested on February 28, 2018 and 2,375 vested on February 28, 2019.  The remaining RSUs will vest in two equal annual installments on the last business day in February, beginning February 28, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 9,500 RSUs, of which 2,375 vested on February 28, 2018 and 2,375 vested on February 28, 2019.  The remaining RSUs will vest in two equal annual installments on the last business day in February, beginning February 28, 2020."}],"balance_after":4750,"derivative":{"underlying":"Common Stock","underlying_shares":2375},"source":{"system":"sec-edgar","filing":"0001140361-19-004274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036119004274/form4.xml","form_type":"4"}},{"id":3622907,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-01T22:35:43.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001140361-19-004274","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036119004274/form4.xml","form_type":"4"}},{"id":3686586,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-26T00:52:36.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 25, 2020, and, thereafter, 1/36th of the remaining option vests in equal installments on each monthly anniversary of such date until fully vested."}],"balance_after":100000,"derivative":{"exercise_price":0.621,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-19-001633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036119001633/form4.xml","form_type":"4"}},{"id":4002952,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-09T22:12:49.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on March 7, 2019, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":200000,"derivative":{"exercise_price":1.78,"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-18-012871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036118012871/form4.xml","form_type":"4"}},{"id":4019520,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T21:39:33.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 9,500 RSUs, of which 2,375 vested on February 28, 2018.  The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 9,500 RSUs, of which 2,375 vested on February 28, 2018.  The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019."}],"balance_after":7125,"derivative":{"underlying":"Common Stock","underlying_shares":2375},"source":{"system":"sec-edgar","filing":"0001140361-18-011667","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036118011667/form4.xml","form_type":"4"}},{"id":4019519,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-02T21:39:33.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2375,"source":{"system":"sec-edgar","filing":"0001140361-18-011667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036118011667/form4.xml","form_type":"4"}},{"id":4084706,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-30T21:26:08.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":45443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 26, 2019, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":45443,"derivative":{"exercise_price":2.29,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":45443},"source":{"system":"sec-edgar","filing":"0001140361-18-003889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036118003889/form4.xml","form_type":"4"}},{"id":4482858,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-24T22:48:01.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."}],"balance_after":95000,"derivative":{"underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001140361-17-002735","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036117002735/form4.xml","form_type":"4"}},{"id":4482857,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":120815,"kind":"person","name":"Benaim Ely","position":1,"cik":"0001632237","reported_name":"Benaim Ely","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-24T22:48:01.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":450000,"derivative":{"exercise_price":0.184,"expiration_date":"2027-01-20","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001140361-17-002735","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036117002735/form4.xml","form_type":"4"}}]}